Related Experiment Video
Updated: Jul 1, 2026

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
Published on: March 3, 2023
Efficacy of gastric per oral endoscopic myotomy for gastroparesis symptoms
Kartik S Akkihal1,2, Marc A Ward3,4,5, Brittany Buckmaster3,4
1Department of Minimally Invasive Surgery, Baylor University Medical Center at Dallas, Dallas, TX, USA. Kartik.Akkihal@BSWHealth.org.
Introduction:
Gastric Per Oral Endoscopic Myotomy (GPOEM) is a procedure used to improve gastroparesis (GP). The Gastroparesis Cardinal Symptom Index (GCSI) is used to assess symptoms subjectively. Although GPOEM has been shown to improve the GCSI score, the individual components of the symptom score have never been evaluated.
Methods And Procedures:
A prospective database was retrospectively reviewed for patients undergoing GPOEM for gastroparesis between January 2020 and June 2025. The GCSI individually reported nausea, retching, vomiting, stomach fullness, inability to finish a normal-sized meal, feeling excessively full after meals, loss of appetite, bloating, and abdominal distension, each rated on a scale of 0-5. Four-hour gastric emptying studies (GES) were collected.
Results:
A total of 167 patients underwent GPOEM during the study period, and 70 (42.0%) were included for having both preoperative and postoperative GCSI available at a mean of 3 months post-GPOEM. Fifty-two (31.1%) of the included cohort also had preoperative and postoperative GES. On average, GCSI and GES values were significantly improved after GPOEM with variable individual responses. Mean GCSI reduced from 26.9 to 16.4 (- 10.4, p < 0.001). Every individual component of the GCSI showed statistically significant improvement, with the largest with loss of appetite (- 1.4, p < 0.001) and belly visibly larger (- 1.4, p < 0.001). Mean GES improved from 42.4% to 19.8% (- 23.8%, p < 0.001).
Conclusion:
This study specifically focused on the effect of GPOEM on each individual component of the GCSI. All symptom scores improved significantly at the cohort level, with the numerically greatest benefits seen in loss of appetite and a visibly larger belly, followed by nausea, vomiting, and stomach fullness. These findings provide additional descriptive information on individual symptom improvement and may help refine patient counseling, while still acknowledging that these data are exploratory in nature and require longer follow-up before allowing treatment-based decisions.
Related Concept Videos
Pyloric Obstruction
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
